Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak

Identifieur interne : 001D19 ( PascalFrancis/Corpus ); précédent : 001D18; suivant : 001D20

Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak

Auteurs : Brendan Healy ; Hugo Van Woerden ; Didier Raoult ; Stephen Graves ; James Pitman ; Graham Lloyd ; Nigel Brown ; Meirion Llewelyn

Source :

RBID : Pascal:11-0256995

Descripteurs français

English descriptors

Abstract

Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1058-4838
A02 01      @0 CIDIEL
A03   1    @0 Clin. infect. dis.
A05       @2 52
A06       @2 8
A08 01  1  ENG  @1 Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak
A11 01  1    @1 HEALY (Brendan)
A11 02  1    @1 VAN WOERDEN (Hugo)
A11 03  1    @1 RAOULT (Didier)
A11 04  1    @1 GRAVES (Stephen)
A11 05  1    @1 PITMAN (James)
A11 06  1    @1 LLOYD (Graham)
A11 07  1    @1 BROWN (Nigel)
A11 08  1    @1 LLEWELYN (Meirion)
A14 01      @1 Public Health Wales, Microbiology Department, UHW Heath Park @2 Cardiff @3 GBR @Z 1 aut.
A14 02      @1 Department of Primary Care and Public Health, Cardiff University @2 Cardiff, Wales @3 GBR @Z 2 aut.
A14 03      @1 Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research @2 Marseille @3 FRA @Z 3 aut.
A14 04      @1 Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital @2 Geelong @3 AUS @Z 4 aut.
A14 05      @1 Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down @2 Salisbury, Wiltshire @3 GBR @Z 5 aut. @Z 6 aut.
A14 06      @1 Department of Cardiology, Royal Gwent Hospital @2 Cardiff Road, Newport @3 GBR @Z 7 aut.
A14 07      @1 Department of Medicine, Royal Gwent Hospital @2 Cardiff Road, Newport @3 GBR @Z 8 aut.
A20       @1 1013-1019
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 18407 @5 354000192120760090
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 29 ref.
A47 01  1    @0 11-0256995
A60       @1 P
A61       @0 A
A64 01  1    @0 Clinical infectious diseases
A66 01      @0 GBR
C01 01    ENG  @0 Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.
C02 01  X    @0 002B05B02L8
C03 01  X  FRE  @0 Fièvre Q @5 01
C03 01  X  ENG  @0 Q fever @5 01
C03 01  X  SPA  @0 Fiebre Q @5 01
C03 02  X  FRE  @0 Chronique @5 07
C03 02  X  ENG  @0 Chronic @5 07
C03 02  X  SPA  @0 Crónico @5 07
C03 03  X  FRE  @0 Etude longitudinale @5 08
C03 03  X  ENG  @0 Follow up study @5 08
C03 03  X  SPA  @0 Estudio longitudinal @5 08
C03 04  X  FRE  @0 Epidémie @5 09
C03 04  X  ENG  @0 Epidemic @5 09
C03 04  X  SPA  @0 Epidemia @5 09
C07 01  X  FRE  @0 Rickettsiose
C07 01  X  ENG  @0 Rickettsial infection
C07 01  X  SPA  @0 Rickettsiosis
C07 02  X  FRE  @0 Rickettsialose
C07 02  X  ENG  @0 Rickettsialosis
C07 02  X  SPA  @0 Rickettsialosis
C07 03  X  FRE  @0 Bactériose
C07 03  X  ENG  @0 Bacteriosis
C07 03  X  SPA  @0 Bacteriosis
C07 04  X  FRE  @0 Infection
C07 04  X  ENG  @0 Infection
C07 04  X  SPA  @0 Infección
N21       @1 171
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0256995 INIST
ET : Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak
AU : HEALY (Brendan); VAN WOERDEN (Hugo); RAOULT (Didier); GRAVES (Stephen); PITMAN (James); LLOYD (Graham); BROWN (Nigel); LLEWELYN (Meirion)
AF : Public Health Wales, Microbiology Department, UHW Heath Park/Cardiff/Royaume-Uni (1 aut.); Department of Primary Care and Public Health, Cardiff University/Cardiff, Wales/Royaume-Uni (2 aut.); Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research/Marseille/France (3 aut.); Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital/Geelong/Australie (4 aut.); Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down/Salisbury, Wiltshire/Royaume-Uni (5 aut., 6 aut.); Department of Cardiology, Royal Gwent Hospital/Cardiff Road, Newport/Royaume-Uni (7 aut.); Department of Medicine, Royal Gwent Hospital/Cardiff Road, Newport/Royaume-Uni (8 aut.)
DT : Publication en série; Niveau analytique
SO : Clinical infectious diseases; ISSN 1058-4838; Coden CIDIEL; Royaume-Uni; Da. 2011; Vol. 52; No. 8; Pp. 1013-1019; Bibl. 29 ref.
LA : Anglais
EA : Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.
CC : 002B05B02L8
FD : Fièvre Q; Chronique; Etude longitudinale; Epidémie
FG : Rickettsiose; Rickettsialose; Bactériose; Infection
ED : Q fever; Chronic; Follow up study; Epidemic
EG : Rickettsial infection; Rickettsialosis; Bacteriosis; Infection
SD : Fiebre Q; Crónico; Estudio longitudinal; Epidemia
LO : INIST-18407.354000192120760090
ID : 11-0256995

Links to Exploration step

Pascal:11-0256995

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak</title>
<author>
<name sortKey="Healy, Brendan" sort="Healy, Brendan" uniqKey="Healy B" first="Brendan" last="Healy">Brendan Healy</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Public Health Wales, Microbiology Department, UHW Heath Park</s1>
<s2>Cardiff</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Woerden, Hugo" sort="Van Woerden, Hugo" uniqKey="Van Woerden H" first="Hugo" last="Van Woerden">Hugo Van Woerden</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Primary Care and Public Health, Cardiff University</s1>
<s2>Cardiff, Wales</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Raoult, Didier" sort="Raoult, Didier" uniqKey="Raoult D" first="Didier" last="Raoult">Didier Raoult</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graves, Stephen" sort="Graves, Stephen" uniqKey="Graves S" first="Stephen" last="Graves">Stephen Graves</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital</s1>
<s2>Geelong</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pitman, James" sort="Pitman, James" uniqKey="Pitman J" first="James" last="Pitman">James Pitman</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down</s1>
<s2>Salisbury, Wiltshire</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lloyd, Graham" sort="Lloyd, Graham" uniqKey="Lloyd G" first="Graham" last="Lloyd">Graham Lloyd</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down</s1>
<s2>Salisbury, Wiltshire</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brown, Nigel" sort="Brown, Nigel" uniqKey="Brown N" first="Nigel" last="Brown">Nigel Brown</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Cardiology, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Llewelyn, Meirion" sort="Llewelyn, Meirion" uniqKey="Llewelyn M" first="Meirion" last="Llewelyn">Meirion Llewelyn</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Medicine, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0256995</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0256995 INIST</idno>
<idno type="RBID">Pascal:11-0256995</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D19</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak</title>
<author>
<name sortKey="Healy, Brendan" sort="Healy, Brendan" uniqKey="Healy B" first="Brendan" last="Healy">Brendan Healy</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Public Health Wales, Microbiology Department, UHW Heath Park</s1>
<s2>Cardiff</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Woerden, Hugo" sort="Van Woerden, Hugo" uniqKey="Van Woerden H" first="Hugo" last="Van Woerden">Hugo Van Woerden</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Primary Care and Public Health, Cardiff University</s1>
<s2>Cardiff, Wales</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Raoult, Didier" sort="Raoult, Didier" uniqKey="Raoult D" first="Didier" last="Raoult">Didier Raoult</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graves, Stephen" sort="Graves, Stephen" uniqKey="Graves S" first="Stephen" last="Graves">Stephen Graves</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital</s1>
<s2>Geelong</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pitman, James" sort="Pitman, James" uniqKey="Pitman J" first="James" last="Pitman">James Pitman</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down</s1>
<s2>Salisbury, Wiltshire</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lloyd, Graham" sort="Lloyd, Graham" uniqKey="Lloyd G" first="Graham" last="Lloyd">Graham Lloyd</name>
<affiliation>
<inist:fA14 i1="05">
<s1>Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down</s1>
<s2>Salisbury, Wiltshire</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Brown, Nigel" sort="Brown, Nigel" uniqKey="Brown N" first="Nigel" last="Brown">Nigel Brown</name>
<affiliation>
<inist:fA14 i1="06">
<s1>Department of Cardiology, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Llewelyn, Meirion" sort="Llewelyn, Meirion" uniqKey="Llewelyn M" first="Meirion" last="Llewelyn">Meirion Llewelyn</name>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Medicine, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Clinical infectious diseases</title>
<title level="j" type="abbreviated">Clin. infect. dis.</title>
<idno type="ISSN">1058-4838</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Chronic</term>
<term>Epidemic</term>
<term>Follow up study</term>
<term>Q fever</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Fièvre Q</term>
<term>Chronique</term>
<term>Etude longitudinale</term>
<term>Epidémie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1058-4838</s0>
</fA01>
<fA02 i1="01">
<s0>CIDIEL</s0>
</fA02>
<fA03 i2="1">
<s0>Clin. infect. dis.</s0>
</fA03>
<fA05>
<s2>52</s2>
</fA05>
<fA06>
<s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>HEALY (Brendan)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>VAN WOERDEN (Hugo)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>RAOULT (Didier)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GRAVES (Stephen)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>PITMAN (James)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>LLOYD (Graham)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BROWN (Nigel)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>LLEWELYN (Meirion)</s1>
</fA11>
<fA14 i1="01">
<s1>Public Health Wales, Microbiology Department, UHW Heath Park</s1>
<s2>Cardiff</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Primary Care and Public Health, Cardiff University</s1>
<s2>Cardiff, Wales</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital</s1>
<s2>Geelong</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down</s1>
<s2>Salisbury, Wiltshire</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Department of Cardiology, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Medicine, Royal Gwent Hospital</s1>
<s2>Cardiff Road, Newport</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA20>
<s1>1013-1019</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18407</s2>
<s5>354000192120760090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>29 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0256995</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Clinical infectious diseases</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B05B02L8</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Fièvre Q</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Q fever</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Fiebre Q</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Chronique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Chronic</s0>
<s5>07</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Crónico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Etude longitudinale</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Follow up study</s0>
<s5>08</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Estudio longitudinal</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Epidémie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Epidemic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Epidemia</s0>
<s5>09</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rickettsiose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rickettsial infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rickettsiosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Rickettsialose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Rickettsialosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Rickettsialosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Bactériose</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Bacteriosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Bacteriosis</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fN21>
<s1>171</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0256995 INIST</NO>
<ET>Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak</ET>
<AU>HEALY (Brendan); VAN WOERDEN (Hugo); RAOULT (Didier); GRAVES (Stephen); PITMAN (James); LLOYD (Graham); BROWN (Nigel); LLEWELYN (Meirion)</AU>
<AF>Public Health Wales, Microbiology Department, UHW Heath Park/Cardiff/Royaume-Uni (1 aut.); Department of Primary Care and Public Health, Cardiff University/Cardiff, Wales/Royaume-Uni (2 aut.); Faculté de Médecine, Unité des Rickettsies, WHO Collaborative Center for Rickettsial Reference and Research/Marseille/France (3 aut.); Australian Rickettsial Reference Laboratory, Barwon Biomedical Research, Barwon Health, Geelong Hospital/Geelong/Australie (4 aut.); Special Pathogens Reference Unit, Centre for Applied Microbiological Research, Porton Down/Salisbury, Wiltshire/Royaume-Uni (5 aut., 6 aut.); Department of Cardiology, Royal Gwent Hospital/Cardiff Road, Newport/Royaume-Uni (7 aut.); Department of Medicine, Royal Gwent Hospital/Cardiff Road, Newport/Royaume-Uni (8 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Clinical infectious diseases; ISSN 1058-4838; Coden CIDIEL; Royaume-Uni; Da. 2011; Vol. 52; No. 8; Pp. 1013-1019; Bibl. 29 ref.</SO>
<LA>Anglais</LA>
<EA>Background. Acute and chronic Q fever/Coxiella burnetii infection is diagnosed principally by serology. The management of patients who have serological evidence of chronic Q fever but no other manifestation of chronic infection is challenging. Methods. This paper describes a follow-up study of individuals 6 years after a point source outbreak. The study compares serological and polymerase chain reaction (PCR) results between 3 international reference laboratories in a well-defined cohort of Q fever patients. Results. Concordance in microimmunofluorescence result interpretation from the 3 centers was only 35%. Australian and UK results had the greatest concordance and French and UK results the lowest. Serological testing revealed no chronic serological profiles when tested in either France or Australia but 10 when tested in the UK. Serological results from a patient with treated Q fever endocarditis suggested treated (France), chronic (UK), and borderline chronic (Australia) infection. PCR results on blood were universally negative. Conclusions. This study has shown that the results from Q fever micro-immunofluorescence vary according to the center in which they are carried out. This has implications for the interpretation of such tests, raises questions regarding the validity of using serological criteria alone as a means of diagnosing chronic Q fever, and affects the interpretation of epidemiological studies. We recommend that all results are interpreted according to the clinical picture and particular caution is applied in the interpretation of chronic serological profiles. In order to further our understanding of Q fever infection we propose that an international standard of Q fever serological investigation be developed.</EA>
<CC>002B05B02L8</CC>
<FD>Fièvre Q; Chronique; Etude longitudinale; Epidémie</FD>
<FG>Rickettsiose; Rickettsialose; Bactériose; Infection</FG>
<ED>Q fever; Chronic; Follow up study; Epidemic</ED>
<EG>Rickettsial infection; Rickettsialosis; Bacteriosis; Infection</EG>
<SD>Fiebre Q; Crónico; Estudio longitudinal; Epidemia</SD>
<LO>INIST-18407.354000192120760090</LO>
<ID>11-0256995</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D19 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001D19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0256995
   |texte=   Chronic Q Fever: Different Serological Results in 3 Countries-Results of a Follow-up Study 6 Years After a Point Source Outbreak
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024